Vistin Pharma ASA (VISTN) — Capital Reinvestment Ratio
Latest as of June 2025:
0.54x
Vistin Pharma ASA (VISTN) has a Capital Reinvestment Ratio of 0.54x as of June 2025, meaning it reinvests 1% of its operating cash flow (Nkr6.37 Million) in capital expenditures (Nkr3.43 Million). See free cash flow generation of Vistin Pharma ASA to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.54x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr6.37 Million
NOK
Capital Expenditures
Nkr3.43 Million
NOK
Data as of
Jun 2025
Most recent filing
Vistin Pharma ASA Capital Reinvestment Ratio (2016–2024)
This chart tracks Vistin Pharma ASA's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Vistin Pharma ASA (2016–2024)
Year-by-year Capital Reinvestment Ratio for Vistin Pharma ASA from 2016 to 2024. For live market cap and broader valuation context, see how much is Vistin Pharma ASA worth.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | Nkr107.86 Million | Nkr40.80 Million | ▲ +91.5% |
| 2023 | 0.20x | Nkr90.59 Million | Nkr17.90 Million | ▼ -91.5% |
| 2021 | 2.33x | Nkr13.68 Million | Nkr31.94 Million | ▲ +140.8% |
| 2019 | 0.97x | Nkr18.93 Million | Nkr18.36 Million | ▼ -74.1% |
| 2017 | 3.74x | Nkr9.51 Million | Nkr35.55 Million | ▲ +1136.9% |
| 2016 | 0.30x | Nkr53.84 Million | Nkr16.27 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow